Striders Impex IPO GMP Today, Price & Details
Striders Impex IPO GMP Today, Price Band, Subscription Status, Allotment & Listing Details
About Striders Impex
Striders Impex is set to launch its Initial Public Offering (IPO) on the NSE SME platform. The company operates within the manufacturing sector, although specific details on its exact sub-segment are not provided in the data. The IPO aims to raise ₹36.29 crore, comprising a fresh issue of ₹32.62 crore and an Offer for Sale (OFS) of ₹3.66 crore.
The fresh capital infusion is earmarked for general corporate purposes and potentially to fuel future growth initiatives, while the OFS component indicates a partial exit for existing shareholders. The company's reported revenue stands at ₹4.01 crore, with a Profit After Tax (PAT) of ₹6.27 crore. This profitability, when viewed against its revenue, suggests a strong margin profile, though the scale of operations appears modest based on the revenue figure.
The IPO offers retail investors an opportunity to participate in a company with reported profitability, albeit from a smaller revenue base. The pricing of the IPO at ₹71 per share, with a face value of ₹10, and a lot size of 1600 shares, sets a minimum investment threshold. The company's competitive positioning and specific market niche are not detailed in the provided data, making it challenging to assess its standing within the broader industry landscape.
Striders Impex IPO — Investment Analysis
Striders Impex's IPO presents a valuation that warrants careful consideration. The company is coming to market with an Earnings Per Share (EPS) of ₹11.33, and a price band fixed at ₹71 per share, resulting in a P/E ratio of 56.51x. This P/E ratio appears elevated, particularly for an SME IPO, and needs to be benchmarked against comparable companies within its operating sector, which is not explicitly defined in the data.
A P/E of 56.51x suggests that investors are paying a significant premium for each rupee of earnings. The company's financial health exhibits a notable contrast between its revenue and profitability. With revenue at ₹4.01 crore and PAT at ₹6.27 crore, the PAT margin is exceptionally high, implying strong operational efficiency or potentially a unique business model.
However, the EBITDA margin is a comparatively lower 1.36%, which might indicate significant depreciation, amortization, or other non-operating expenses impacting the EBITDA. Return ratios are mixed: Return on Net Worth (RONW) is 10.81%, which is moderate, while Return on Capital Employed (ROCE) at 15.07% is more robust, suggesting better utilization of deployed capital. The company's growth outlook is difficult to ascertain from the provided data alone.
The substantial PAT relative to revenue could suggest a profitable niche, but the limited revenue figure might indicate a nascent or specialized operation. The growth trajectory of revenue is not evident. Key risks for this IPO include the high valuation, as indicated by the P/E ratio, which might be a concern for investors seeking value.
The disparity between PAT and EBITDA margins could also signal underlying complexities in the cost structure. Furthermore, the significant portion of the IPO being a fresh issue (₹32.62 crore) versus a smaller OFS (₹3.66 crore) suggests a focus on capital infusion for growth, but the success of this growth will depend on the deployment of these funds. SME IPOs, in general, carry higher risks due to their smaller scale and potentially less established track records.
Subscription sentiment, if available, would provide crucial insights into market demand and investor confidence. Investors should consult a SEBI-registered financial advisor before making investment decisions.
Disclaimer: This analysis is auto-generated from publicly available financial data and should not be considered investment advice. Always consult a SEBI-registered financial advisor before making investment decisions.
Striders Impex IPO — Pros & Cons
Strengths
- The company has demonstrated strong profitability with a PAT of ₹6.27 Cr against a revenue of ₹4.01 Cr. This high profit suggests efficient operations or a niche market where the company commands strong pricing power, which could translate to sustained earnings for investors.
- The ROCE of 15.07% indicates efficient utilization of capital employed in the business. A higher ROCE suggests that the company is generating good returns on the money invested, a positive sign for operational effectiveness and future growth potential.
- The Net Asset Value (NAV) per share of ₹57.96 provides a baseline book value for the company's assets. Given the issue price of ₹71, the premium to NAV is not excessively high, offering some tangible asset backing to the investment.
- The IPO includes a fresh issue component of ₹32.62 Cr, which will augment the company's capital base. This infusion of funds can be used for expansion, working capital, or other strategic initiatives, potentially driving future revenue and profit growth.
- The EBITDA margin, while modest at 1.36%, is a positive indicator of operational earnings before interest, taxes, depreciation, and amortization. This metric helps in understanding the core operational profitability of the business.
Risks
- The P/E ratio of 56.51x appears quite high, especially for an SME IPO, suggesting that the stock might be overvalued at the current price band. Investors paying this multiple are betting on substantial future earnings growth that may be difficult to achieve.
- There is a significant disparity between the reported PAT (₹6.27 Cr) and the EBITDA margin (1.36%). This could indicate substantial non-cash expenses like depreciation and amortization, or other factors impacting the operating cash flow, warranting deeper investigation into the cost structure.
- The revenue base of ₹4.01 Cr is relatively small, which could imply a nascent or niche business. Growth from such a small base, while potentially high in percentage terms, might not translate into significant absolute profit increases in the short to medium term.
- The Offer for Sale (OFS) component of ₹3.66 Cr indicates that some existing shareholders are looking to exit their investment through the IPO. While not always a negative sign, it can sometimes suggest a lack of strong conviction in future growth by those closest to the business.
- The Return on Net Worth (RONW) of 10.81% is moderate, suggesting that while the company is profitable, it is not generating exceptionally high returns on shareholder equity. This could be a concern for investors seeking businesses with superior capital efficiency.
Striders Impex IPO Details
| Company Name | Striders Impex |
|---|---|
| IPO Type | SME |
| Exchange | NSE |
| Price Band | ₹71 - ₹71 |
| Face Value | ₹10 per share |
| Lot Size | 1600 shares |
| Min Investment | ₹113,600 |
| Total Issue Size | ₹36.29 Cr |
|---|---|
| Fresh Issue | ₹32.62 Cr |
| Offer for Sale | ₹3.66 Cr |
| Registrar | 6.27 |
| IPO Status | Upcoming |
Striders Impex IPO Dates
Striders Impex IPO GMP Today
The Grey Market Premium (GMP) for Striders Impex IPO is not available.
Striders Impex IPO — Key Highlights
- Striders Impex is raising ₹36.29 Cr through its IPO on the NSE SME platform.
- The IPO has a fixed price band of ₹71 per share with a face value of ₹10.
- The company reported a Profit After Tax (PAT) of ₹6.27 Cr on a revenue of ₹4.01 Cr.
- The P/E ratio stands at a high 56.51x, based on an EPS of ₹11.33.
- A substantial ₹32.62 Cr is from fresh issue, intended for corporate purposes.
- The company has a ROCE of 15.07% and RONW of 10.81%.
Striders Impex Financial Performance
| Revenue | ₹4.01 Cr |
|---|---|
| PAT | ₹6.27 Cr |
| EPS | ₹11.33 |
Striders Impex IPO Valuations & Key Metrics
Valuation Ratios
| EPS | ₹11.33 |
|---|---|
| P/E Ratio | 56.51x |
| NAV | ₹57.96 |
| Current Ratio | 36.00 |
| Debt/Equity | 10.810 |
Return Metrics
| RONW (%) | 10.81% |
|---|---|
| ROCE (%) | 15.07% |
| EBITDA Margin | 1.36% |
| Employees | 2,147,483,647 |
Striders Impex IPO Reservation / Allocation
Striders Impex IPO Anchor Investors
| Bid Date | 25 February 2026 |
|---|---|
| Shares Offered | 14,33,600 shares |
| Anchor Portion (INR Cr.) | INR 10.32 crore |
| Anchor lock-in period end date for 50% shares (30 Days) | 30 March 2026 |
| Anchor lock-in period end date for remaining shares (90 Days) | 2 June 2026 |
Striders Impex IPO Lead Manager & Registrar
IPO Registrar
6.27
Striders Impex IPO — Frequently Asked Questions
What is Striders Impex IPO GMP today?
As of today, the Grey Market Premium (GMP) for Striders Impex IPO is not available at this time. GMP values are updated daily based on grey market activity.
What is the price band and lot size of Striders Impex IPO?
Striders Impex IPO has a price band of ₹71 to ₹71 per equity share with a face value of ₹10. The minimum lot size is 1600 shares, requiring a minimum investment of ₹113,600 at the upper band.
What are the important dates for Striders Impex IPO?
Striders Impex IPO opens for subscription on 26 Feb 2026 and closes on 02 Mar 2026. Allotment is expected on 04 Mar 2026. The shares are expected to list on NSE on 06 Mar 2026.
How can I apply for Striders Impex IPO?
You can apply for Striders Impex IPO through your bank's net banking ASBA facility or via UPI-based application through any stockbroker platform. Ensure you have sufficient funds in your bank account as the amount will be blocked until allotment. The registrar for this IPO is 6.27.
What is Striders Impex IPO price band and lot size?
The Striders Impex IPO has a fixed price band of ₹71 per share, meaning the offer price is set at ₹71. The face value of each share is ₹10. The lot size for this IPO is 1600 shares, which means the minimum investment for retail investors is ₹113,600 (1600 shares * ₹71 per share). Retail investors can typically apply for up to two lots in an SME IPO, subject to application limits.
Is Striders Impex IPO worth investing in?
Striders Impex presents a profitable business with a ROCE of 15.07% and a PAT margin that appears strong relative to its revenue. However, the P/E ratio of 56.51x is on the higher side, indicating a potentially rich valuation. The company's growth prospects will depend on how effectively it deploys the fresh capital raised. Investors should weigh the profitability and capital efficiency against the valuation concerns and the general risks associated with SME IPOs. It is advisable to conduct thorough due diligence and consult a SEBI-registered financial advisor before making any investment decisions.
What is Striders Impex IPO GMP today?
Grey Market Premium (GMP) for an IPO is an unofficial indicator of market sentiment and demand. It reflects the premium at which IPO shares are trading in the unofficial market before listing. While a positive GMP can suggest strong investor interest, it is not a guaranteed predictor of listing gains and should not be the sole basis for investment decisions. For the most current GMP, one would need to refer to specialized IPO tracking platforms or forums, keeping in mind its speculative nature.
How to apply for Striders Impex IPO?
You can apply for the Striders Impex IPO through your stockbroker's trading platform using the Unified Payments Interface (UPI) mechanism. Alternatively, you can apply via the ASBA (Applications Supported by Blocked Amount) facility through your bank's net banking portal. The registrar for this IPO is 6.27. Your funds will remain blocked in your bank account until the shares are allotted, after which they will be debited only if you receive an allotment.